StonvexLoading…
StonvexStonvexStonvexCore line items from CSBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $45.59M | $29.03M | $13.99M | $56.94M |
Operating Income | $-618.00K | $-342.00K | $-527.00K | $4.55M |
Net Income | $-508.00K | $-169.00K | $-436.00K | $4.70M |
EPS (Diluted) | $-0.04 | $-0.01 | $-0.03 | $0.33 |
Total Assets | $28.45M | $30.16M | $30.55M | $32.34M |
Total Liabilities | $24.07M | $25.93M | $27.01M | $28.57M |
Cash & Equivalents | $7.13M | $8.52M | $10.32M | $9.79M |
Free Cash Flow OCF − CapEx | $-2.80M | $-1.42M | $554.00K | $7.00M |
Shares Outstanding | 13.89M | 13.89M | 13.79M | 13.78M |